We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop Clinical Diagnostics

By HospiMedica staff writers
Posted on 23 Sep 2002
A major collaboration to develop and commercialize clinical diagnostics and research products has been announced by Ribonomics, Inc. More...
(Research Triangle Park, NC, USA) and Medical & Biological Laboratories Co., Ltd. (MBL, Nagoya, Japan). The alliance combines MBL's product development and commercialization expertise with the target discovery process and systems biology data of Ribonomics.

Under the terms of the agreement, Ribonomics will use its proprietary RAS platform technology to discover new diagnostic biomarkers that rapidly and accurately detect disease. In return for an upfront technology fee, MBL has secured the first right of access to develop, manufacture, and commercialize products directed at disease markers discovered by Ribonomics. In cases where MBL elects to develop a product covered by the collaboration, Ribonomics will receive licensing fees as well as milestone payments and royalties, as specified.

"This collaboration will benefit MBL incredibly in that it will allow MBL to gain access to novel diagnostic targets discovered by Ribonomics and enable MBL to quickly advance the development of research and diagnostic products,” said Sachiko Suno, chairman of MBL.





Related Links:
Ribonomics
MBL

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.